Key Takeaways
What Is the Cause of Depression in the Brain? The Short Answer
Research has not found one cause of depression in the brain. The National Institute of Mental Health states that genetic, biological, environmental and psychological factors all play a role in depression[6].
What brain studies do find is a set of small, average differences in structure, network activity, stress hormones and inflammation. In a large single-cohort test, a 2022 JAMA Psychiatry study of 1,809 adults, the largest brain difference between groups explained at most 1.7% of the variance, and brain scans sorted people into the right group only 54% to 56% of the time[1].
That is close to a coin flip. The authors concluded that similarity between depressed and healthy brains dominated and that single-person prediction was not possible[1].
This post covers the brain side of the question. For the wider picture of genes, life stress and medical causes, see what is the cause of depression, and for how common the condition is, see the depression statistics page.
Overlap between brain measures of adults with and without major depression, for the single most different measure in each scan type
Even the biggest brain differences in this harmonized cohort of 861 patients and 948 controls left the two groups mostly indistinguishable. Classification accuracy ranged from 54% to 56%.
"distributions overlapped between 87% and 95%"
Which Parts of the Brain Are Involved in Depression?
No single region is responsible. Studies point to circuits linking the hippocampus, amygdala, prefrontal cortex, anterior cingulate and the striatum, each tied to a different part of the experience of depression.
Hippocampus
The hippocampus supports memory and helps switch off the stress response. The ENIGMA consortium pooled MRI scans from 15 research samples and found significantly lower hippocampal volume in major depression, with a Cohen’s d of −0.14[2].
Amygdala
The amygdala processes threat and negative emotion. In the same ENIGMA analysis, people whose depression began at or before age 21 showed only a trend toward a smaller amygdala (d = −0.11)[2].
Prefrontal cortex and cingulate
Frontal control regions regulate emotion and attention. A meta-analysis of 25 resting-state publications found weaker connectivity within the frontoparietal control network and weaker links between emotion-processing systems and midline cortical regions thought to regulate them[7].
Striatum and the reward system
The striatum, which includes the caudate and nucleus accumbens, responds to reward. A 2018 meta-analysis of 38 fMRI studies found reduced striatal activation in depressed people when they received rewards[8]. Loss of interest or pleasure, called anhedonia, is a core symptom of depression, which is why the reward system draws so much research.
In longitudinal studies in the review, reduced striatal activation came before the onset of depression in adolescents[8]. That timing suggests the reward circuit may be part of vulnerability, not only a result of being depressed.
Brain and Body Differences Linked to Depression in Large Studies
| Measure | Finding in depression | Size of difference | Study and sample |
|---|---|---|---|
| Hippocampal volume | Smaller | d = −0.14 (−1.24%) | ENIGMA, 1,728 vs 7,199 (2016) |
| Hippocampus, recurrent MDD | Smaller | d = −0.17 (−1.44%) | ENIGMA (2016) |
| Hippocampus, first episode | No difference | Not significant | ENIGMA (2016) |
| Striatal response to reward | Reduced | Pooled across 38 fMRI studies | Keren et al. (2018) |
| Default mode network | Hyperconnected | Pooled across 27 data sets | 556 vs 518 (2015) |
| Cortisol | Higher | d = 0.60 (0.33 in quality studies) | 361 studies, 18,454 people (2011) |
| CRP above 3 mg/L | 27% of patients | Odds ratio 1.46 vs matched controls | Osimo et al. (2019) |
| Serum BDNF, untreated | Lower | d = −0.71 | 2,384 vs 2,982 (2014) |
| Any single MRI measure | Mostly overlapping | Accuracy 54%–56% | 861 vs 948 (2022) |
Selected meta-analyses and large cohorts comparing people with major depression with healthy controls[2][8][7][3][4][9][1].
1All findings are group averages from mostly cross-sectional studies; they do not show that the difference caused depression.
2d = Cohen’s d (standardized mean difference); CRP = C-reactive protein; BDNF = brain-derived neurotrophic factor.
Sources
- •Schmaal et al., Molecular Psychiatry, 2016
- •Keren et al., American Journal of Psychiatry, 2018
- •Kaiser et al., JAMA Psychiatry, 2015
- •Stetler and Miller, Psychosomatic Medicine, 2011
- •Osimo et al., Psychological Medicine, 2019
- •Molendijk et al., Molecular Psychiatry, 2014
- •Winter et al., JAMA Psychiatry, 2022
Does Depression Shrink the Brain?
On average, slightly, and mainly in the hippocampus. In ENIGMA’s 2016 analysis, the hippocampus was 1.24% smaller in people with major depression than in controls[2].
The difference was concentrated in recurrent depression, where it reached 1.44%, and the researchers found no difference between people in a first episode and controls[2]. Onset at or before age 21 was linked to a 1.85% smaller hippocampus[2].
Symptom severity at the time of the scan was not associated with any regional brain volume[2]. Because the pattern tracks repeated episodes rather than the first one, it fits the possibility that some changes follow illness rather than precede it, though cross-sectional data cannot settle which way the arrow points.
Trauma-related brain changes are a separate question; the explainer on how trauma affects the brain covers the circuits involved in PTSD.
How Brain Networks Work Differently in Depression
Much of the newer research looks at how regions communicate rather than how big they are. The 2015 JAMA Psychiatry meta-analysis pooled 27 resting-state data sets covering 556 people with major depression and 518 controls[7].
It found hyperconnectivity within the default mode network and between that network and frontoparietal control regions, alongside hypoconnectivity within the control network itself[7].
The authors read this as a brain tilted toward internal thought at the cost of engaging with the outside world, a pattern that fits rumination[7]. That reading is an interpretation of group data, not a measured cause.
Default mode network
A set of brain regions whose activity is coordinated at rest and which is believed to support internally oriented and self-referential thought[7].
Related Terms
Source: Kaiser et al., JAMA Psychiatry, 2015
How Stress Hormones Affect the Brain in Depression
The hypothalamic-pituitary-adrenal (HPA) axis is the body’s main stress-hormone system, ending in the release of cortisol. A meta-analysis of 361 studies and 18,454 people found that depressed individuals tended to have higher cortisol (d = 0.60) and higher adrenocorticotropic hormone (d = 0.28)[3].
The cortisol effect fell to d = 0.33 when the analysis was limited to studies meeting minimal methodological standards[3]. Differences were larger in older hospitalized patients than in younger outpatients, and they appeared in melancholic, psychotic, atypical and endogenous forms of depression[3].
The hormone that starts the cascade, corticotropin-releasing hormone, was not elevated (d = 0.02)[3]. HPA differences are therefore an average tendency rather than a universal feature, and they are largest in severe, inpatient presentations.
Can Inflammation Cause Depression?
Inflammation is associated with depression in a sizable subgroup, but a causal role has not been established for most people. A 2019 meta-analysis of 37 studies covering 13,541 depressed patients found that 27% had low-grade inflammation, defined as C-reactive protein (CRP) above 3 mg/L[4].
Mildly elevated CRP, above 1 mg/L, was present in 58% of patients[4]. Compared with matched healthy controls, people with depression had 1.46 times the odds of low-grade inflammation[4]. The odds of mildly elevated CRP were 1.47 times higher than in controls[4].
That prevalence did not differ by inpatient or outpatient setting, antidepressant use, age, BMI or ethnicity[4]. The authors concluded that inflammation could be relevant to a large number of patients with depression, and they describe peripheral low-grade inflammation as increasingly seen as a therapeutic target[4].
Is Depression a Chemical Imbalance in the Brain?
Not in the simple low-serotonin sense. A 2022 umbrella review in Molecular Psychiatry examined 17 reviews and large studies and found no consistent evidence of an association between serotonin and depression, and no support for the idea that lowered serotonin causes it[5].
The two largest genetic studies in that review, with 115,257 and 43,165 participants, found no link between the serotonin transporter gene and depression[5]. A meta-analysis of cohort studies of plasma serotonin (n = 1,869) showed no relationship with depression, and lower serotonin concentration was associated with antidepressant use[5].
Tryptophan depletion, which temporarily lowers serotonin, had no effect on mood in most healthy volunteers (n = 566), with weak evidence of an effect in those with a family history of depression (n = 75)[5]. The fuller debate, including critiques of the review, is covered in is depression a chemical imbalance.
Glutamate and NMDA receptors
Attention has shifted toward glutamate, the brain’s main excitatory messenger. The FDA approved esketamine nasal spray, a non-competitive NMDA receptor antagonist, on March 5, 2019[10][11].
Its current label covers treatment-resistant depression in adults and depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior[11]. A drug that works through glutamate receptors does not show that a glutamate deficit causes depression, in the same way that SSRIs did not prove a serotonin deficit.
BDNF and neuroplasticity
Brain-derived neurotrophic factor (BDNF) is a protein that supports the growth and connection of neurons. A 2014 meta-analysis found lower serum BDNF in 2,384 antidepressant-free depressed patients than in 2,982 healthy controls (d = −0.71) and than in 1,249 antidepressant-treated patients (d = −0.56)[9].
BDNF levels were not consistently related to how severe symptoms were, and the authors described the evidence as slimmer than first thought and amid a lot of noise[9]. Medication options are compared in anti-depression meds.
Can a Brain Scan Diagnose Depression?
No. In the 2022 Marburg-Münster study, every scan type tested, including structural MRI, diffusion imaging, task-based fMRI and resting-state fMRI, classified individuals correctly only 54% to 56% of the time[1].
The result held when the researchers looked only at acute or only at chronic depression[1]. Brain differences were about as small as those explained by a polygenic risk score and substantially smaller than differences in the environmental variables the study measured[1].
Depression is still diagnosed from symptoms using criteria such as the DSM-5 depression criteria. For the genetic side of risk, see is depression genetic.
Frequently Asked Questions
Sources & References
- Winter NR, Leenings R, Ernsting J, et al. Quantifying Deviations of Brain Structure and Function in Major Depressive Disorder Across Neuroimaging Modalities. JAMA Psychiatry. Published 2022. Accessed October 2026. https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2794429 [Link]
- Schmaal L, Veltman DJ, van Erp TGM, et al. Subcortical brain alterations in major depressive disorder: findings from the ENIGMA Major Depressive Disorder working group. Molecular Psychiatry. Published 2016. Accessed October 2026. https://www.nature.com/articles/mp201569 [Link]
- Stetler C, Miller GE. Depression and Hypothalamic-Pituitary-Adrenal Activation: A Quantitative Summary of Four Decades of Research. Psychosomatic Medicine. Published 2011. Accessed October 2026. https://doi.org/10.1097/PSY.0b013e31820ad12b [Link]
- Osimo EF, Baxter LJ, Lewis G, Jones PB, Khandaker GM. Prevalence of low-grade inflammation in depression: a systematic review and meta-analysis of CRP levels. Psychological Medicine. Published 2019. Accessed October 2026. https://doi.org/10.1017/S0033291719001454 [Link]
- Moncrieff J, Cooper RE, Stockmann T, Amendola S, Hengartner MP, Horowitz MA. The serotonin theory of depression: a systematic umbrella review of the evidence. Molecular Psychiatry. Published 2022. Accessed October 2026. https://www.nature.com/articles/s41380-022-01661-0 [Link]
- National Institute of Mental Health. Depression. National Institutes of Health. Published 2024. Accessed October 2026. https://www.nimh.nih.gov/health/topics/depression [Link]
- Kaiser RH, Andrews-Hanna JR, Wager TD, Pizzagalli DA. Large-Scale Network Dysfunction in Major Depressive Disorder: A Meta-analysis of Resting-State Functional Connectivity. JAMA Psychiatry. Published 2015. Accessed October 2026. https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2203837 [Link]
- Keren H, O'Callaghan G, Vidal-Ribas P, et al. Reward Processing in Depression: A Conceptual and Meta-Analytic Review Across fMRI and EEG Studies. American Journal of Psychiatry. Published 2018. Accessed October 2026. https://psychiatryonline.org/doi/10.1176/appi.ajp.2018.17101124 [Link]
- Molendijk ML, Spinhoven P, Polak M, Bus BAA, Penninx BWJH, Elzinga BM. Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (N=9484). Molecular Psychiatry. Published 2014. Accessed October 2026. https://www.nature.com/articles/mp2013105 [Link]
- Farchione TR. NDA 211243 approval letter: Spravato (esketamine) nasal spray. U.S. Food and Drug Administration. Published 2019. Accessed October 2026. https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/211243Orig1s000ltr.pdf [Link]
- Janssen Pharmaceuticals. Spravato (esketamine) nasal spray prescribing information. U.S. Food and Drug Administration. Published 2025. Accessed October 2026. https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/211243s016lbl.pdf [Link]